-
Systematic Review of Effectiveness of SGLT2 Inhibitors in Patients With Type 2 Diabetes With Focus on Glucose Levels, Cardiovascular Events, and Renal Function
Sep 9, 2025, 16:22 PM -
Measures for Integrating Carbon Footprints Into Economic Evaluations: A Targeted Review of Environmental and Economic Metrics
Sep 9, 2025, 16:22 PM -
International Reference Pricing (IRP) Analysis for Generic Medicines in Türkiye in 2024
Sep 9, 2025, 16:22 PM -
Expert Consensus on a Definition for Children With Medical Complexity in England: A Modified Delphi Panel
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Familial Hypercholesterolemia Cascade Testing in Thailand: A Comparative Analysis of Exome vs. Long-Read DNA Sequencing
Sep 9, 2025, 16:22 PM -
Impact of Different CV Risk Estimation Methods on Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
Quantifying the Opportunity Costs of Intra-Direct Oral Anticoagulants (DOAC) Switching Pathways Across the National Health Service (NHS) in England: A Structured Framework
Sep 9, 2025, 16:22 PM -
Delayed Access to Diabetes Technology in Children With Migration Background: A Cross-Sectional Study on Treatment Equity in Austria
Sep 9, 2025, 16:22 PM -
Pharmacoeconomic and Healthcare Aspects of the TDM-Guided Decisions on Biological Treatment of Inflammatory Diseases: Systematic Review of International Evidence
Sep 9, 2025, 16:22 PM -
Developing the Next Generation of Therapeutics: The Role of Early Model-Based Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
The Public Health and Economic Effects of Various RSV Vaccination Strategies With RSVpreF Among Adults in France
Sep 9, 2025, 16:22 PM -
Trends and Tensions in NICE Severity Modifiers: Analyzing the Acceptance and Critique of Manufacturer Severity Modifier Proposals in Recent Appraisals
Sep 9, 2025, 16:22 PM -
How Publication Bias May Overestimate the Risk of Serious Adverse Events Associated With Bisphosphonate Use
Sep 9, 2025, 16:22 PM -
Characterizing Medicines Reimbursed Under Managed Access Protocols in Ireland (2006-2025)
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of I-CREATE: An Inpatient Intrinsic Capacity Risk Evaluation Towards Holistic Assessment and Targeted Management of Elderly in Acute Care
Sep 9, 2025, 16:22 PM -
Budget Impact of Anakinra in Turkiye: An Analysis From the Social Security Institution’s Perspective
Sep 9, 2025, 16:22 PM -
Potential Implications of EU Joint Clinical Assessment (JCA) for the UK Affiliate of a Global Pharmaceutical Company
Sep 9, 2025, 16:22 PM -
Quality of Life and Productivity Costs in Cancer Patients Receiving Proton Therapy: A Predictive and Descriptive Study
Sep 9, 2025, 16:22 PM -
To Be or Not to Be Willing to Pay
Sep 9, 2025, 16:22 PM -
Improving Kidney Exchange Program Effectiveness and Equity by Using Allele and Eplet HLA Compatibility Technologies
Sep 9, 2025, 16:22 PM
